185 related articles for article (PubMed ID: 12716765)
1. A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects.
Sesti G; Cardellini M; Marini MA; Frontoni S; D'Adamo M; Del Guerra S; Lauro D; De Nicolais P; Sbraccia P; Del Prato S; Gambardella S; Federici M; Marchetti P; Lauro R
Diabetes; 2003 May; 52(5):1280-3. PubMed ID: 12716765
[TBL] [Abstract][Full Text] [Related]
2. The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes.
D'Adamo M; Perego L; Cardellini M; Marini MA; Frontoni S; Andreozzi F; Sciacqua A; Lauro D; Sbraccia P; Federici M; Paganelli M; Pontiroli AE; Lauro R; Perticone F; Folli F; Sesti G
Diabetes; 2004 Jul; 53(7):1905-10. PubMed ID: 15220218
[TBL] [Abstract][Full Text] [Related]
3. The common -866G/A polymorphism in the promoter region of the UCP-2 gene is associated with reduced risk of type 2 diabetes in Caucasians from Italy.
Bulotta A; Ludovico O; Coco A; Di Paola R; Quattrone A; Carella M; Pellegrini F; Prudente S; Trischitta V
J Clin Endocrinol Metab; 2005 Feb; 90(2):1176-80. PubMed ID: 15562023
[TBL] [Abstract][Full Text] [Related]
4. The frequent UCP2 -866G>A polymorphism protects against insulin resistance and is associated with obesity: a study of obesity and related metabolic traits among 17 636 Danes.
Andersen G; Dalgaard LT; Justesen JM; Anthonsen S; Nielsen T; Thørner LW; Witte D; Jørgensen T; Clausen JO; Lauritzen T; Holmkvist J; Hansen T; Pedersen O
Int J Obes (Lond); 2013 Feb; 37(2):175-81. PubMed ID: 22349573
[TBL] [Abstract][Full Text] [Related]
5. The A allele of the UCP2 -866G/A polymorphism changes UCP2 promoter activity in HUVECs treated with high glucose.
Crispim D; Rodrigues M; da Silva LPA; Bouças AP; Canani LH; Carlessi R; de Souza BM
Mol Biol Rep; 2019 Oct; 46(5):4735-4741. PubMed ID: 31218541
[TBL] [Abstract][Full Text] [Related]
6. Interaction between the UCP2 -866 G>A polymorphism, diabetes, and beta-blocker use among patients with acute coronary syndromes.
Beitelshees AL; Finck BN; Leone TC; Cresci S; Wu J; Province MA; Fabbrini E; Kirk E; Zineh I; Klein S; Spertus JA; Kelly DP
Pharmacogenet Genomics; 2010 Apr; 20(4):231-8. PubMed ID: 20145583
[TBL] [Abstract][Full Text] [Related]
7. Uncoupling protein 2 promoter polymorphism -866G/A affects its expression in beta-cells and modulates clinical profiles of Japanese type 2 diabetic patients.
Sasahara M; Nishi M; Kawashima H; Ueda K; Sakagashira S; Furuta H; Matsumoto E; Hanabusa T; Sasaki H; Nanjo K
Diabetes; 2004 Feb; 53(2):482-5. PubMed ID: 14747301
[TBL] [Abstract][Full Text] [Related]
8. Uncoupling protein 2 -866G/A and uncoupling protein 3 -55C/T polymorphisms in young South African Indian coronary artery disease patients.
Phulukdaree A; Moodley D; Khan S; Chuturgoon AA
Gene; 2013 Jul; 524(2):79-83. PubMed ID: 23639961
[TBL] [Abstract][Full Text] [Related]
9. A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans.
Krempler F; Esterbauer H; Weitgasser R; Ebenbichler C; Patsch JR; Miller K; Xie M; Linnemayr V; Oberkofler H; Patsch W
Diabetes; 2002 Nov; 51(11):3331-5. PubMed ID: 12401727
[TBL] [Abstract][Full Text] [Related]
10. The -866G/A polymorphism in the promoter of the UCP2 gene is associated with risk for type 2 diabetes and with decreased insulin levels.
Gomathi P; Samarth AP; Raj NBAJ; Sasikumar S; Murugan PS; Nallaperumal S; Selvam GS
Gene; 2019 Jun; 701():125-130. PubMed ID: 30910560
[TBL] [Abstract][Full Text] [Related]
11. The presence of the -866A/55Val/Ins haplotype in the uncoupling protein 2 (UCP2) gene is associated with decreased UCP2 gene expression in human retina.
de Souza BM; Assmann TS; Kliemann LM; Marcon AS; Gross JL; Canani LH; Crispim D
Exp Eye Res; 2012 Jan; 94(1):49-55. PubMed ID: 22134120
[TBL] [Abstract][Full Text] [Related]
12. Simple and rapid detection of uncoupling protein-2 - 866G/A polymorphism by mutagenically separated polymerase chain reaction.
Zhang B; Tanaka H; Saku K
Clin Chim Acta; 2004 Jun; 344(1-2):205-10. PubMed ID: 15149891
[TBL] [Abstract][Full Text] [Related]
13. Beta-cell uncoupling protein 2 regulates reactive oxygen species production, which influences both insulin and glucagon secretion.
Robson-Doucette CA; Sultan S; Allister EM; Wikstrom JD; Koshkin V; Bhattacharjee A; Prentice KJ; Sereda SB; Shirihai OS; Wheeler MB
Diabetes; 2011 Nov; 60(11):2710-9. PubMed ID: 21984579
[TBL] [Abstract][Full Text] [Related]
14. Variants of uncoupling protein-2 gene and obesity: interaction with peroxisome proliferator-activated receptorgamma2.
Mancini FP; Sabatino L; Colantuoni V; Pasanisi F; Finelli C; Contaldo F; Masulli M; Riccardi G; Vaccaro O
Clin Endocrinol (Oxf); 2003 Dec; 59(6):817-22. PubMed ID: 14974928
[TBL] [Abstract][Full Text] [Related]
15. Correlation between pancreatic islet uncoupling protein-2 (UCP2) mRNA concentration and insulin status in rats.
Kassis N; Bernard C; Pusterla A; Casteilla L; Pénicaud L; Richard D; Ricquier D; Ktorza A
Int J Exp Diabetes Res; 2000; 1(3):185-93. PubMed ID: 11467409
[TBL] [Abstract][Full Text] [Related]
16. Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion.
Wang H; Chu WS; Lu T; Hasstedt SJ; Kern PA; Elbein SC
Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E1-7. PubMed ID: 12915397
[TBL] [Abstract][Full Text] [Related]
17. -866G/A and Ins/Del polymorphisms in UCP2 gene are associated with reduced short-term weight loss in patients who underwent Roux-en-Y gastric bypass.
de Oliveira MS; Rodrigues M; Rossoni EA; Sortica DA; Rheinheimer J; Moehlecke M; Heredia MLDC; Horvath JDC; Kops NL; Trindade MRM; Viana LV; Leitão CB; Friedman R; Crispim D; de Souza BM
Surg Obes Relat Dis; 2021 Jul; 17(7):1263-1270. PubMed ID: 33941479
[TBL] [Abstract][Full Text] [Related]
18. Association study between the -866G/A polymorphism in the promoter of uncoupling protein-2 gene and polycystic ovary syndrome.
Kim JH; Li L; Yun JH; Choi BC; Baek KH
Mol Med Rep; 2011; 4(4):747-51. PubMed ID: 21584501
[TBL] [Abstract][Full Text] [Related]
19. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes.
Zhang CY; Baffy G; Perret P; Krauss S; Peroni O; Grujic D; Hagen T; Vidal-Puig AJ; Boss O; Kim YB; Zheng XX; Wheeler MB; Shulman GI; Chan CB; Lowell BB
Cell; 2001 Jun; 105(6):745-55. PubMed ID: 11440717
[TBL] [Abstract][Full Text] [Related]
20. Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high-fat diet.
Joseph JW; Koshkin V; Zhang CY; Wang J; Lowell BB; Chan CB; Wheeler MB
Diabetes; 2002 Nov; 51(11):3211-9. PubMed ID: 12401712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
